Modulation of the tumour microenvironment in hepatocellular carcinoma by tyrosine kinase inhibitors: from modulation to combination therapy targeting the microenvironment
Cancer Cell International,
Hepatocellular carcinoma (HCC) is the third leading cause of cancer deaths worldwide.